Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine TDS-Testosterone 5% in Adult Male Subjects

NCT01894308 is registered in ClinicalTrials.gov with Transdermal Delivery Solutions Corp as lead sponsor.

NCT NCT01894308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01894308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine TDS-Testosterone 5% in Adult Male Subjects
Lead sponsor
Transdermal Delivery Solutions Corp
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2027
Completion date
February 29, 2028
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadotropism